Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(12 sites)
United States
The Angeles Clinic and Research Institute, Los Angeles, California START Midwest, Grand Rapids, Michigan START-New York Long Island, Lake Success, New York Providence Cancer Institute, Portland, Oregon The University of Texas MD Anderson Cancer Center, Houston, Texas University of Texas Health Science Center at Houston, Houston, Texas START Mountain Region, West Valley City, Utah Australia
ICON Cancer Centre Wesley, Auchenflower, Queensland ICON Cancer Centre Kurralta Park, Kurralta Park, South Australia Austin Health- Olivia Newton John Cancer Center, Heidelberg, Victoria United Kingdom
Oxford University Hospitals NHS Foundation Trust, Oxford The Royal Marsden NHS Foundation Trust, Sutton